is there withdrawal from semaglutide Two-year effects of in adults with overweight or obesity: the STEP 5 trial Reasons for Discontinuation of Obesity

This therapy is commonly considered when: Weight management has been difficult despite lifestyle efforts Blood sugar or metabolic markers require clinical support Appetite regulation is a concern Ongoing provider monitoring is preferred Men receiving care at our Frederick clinic are evaluated individually to ensure GLP-1 therapy aligns with their health profile and treatment goals

How do we create the optimal plan for each patient? Research should also further explore the psychological impact of weight-loss treatment, including the risk of eating disorders, say those involved

2023;46(Suppl 1):S15890

I should have addressed it

Salehi P, Hsu I, Azen CG, Mittelman SD, Geffner ME, Jeandron D

Statins remain first-line treatment for cholesterol management in people with type 2 diabetes according to NICE guidance